CTI Biopharma Corp
F:CEPS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CTI Biopharma Corp
F:CEPS
|
US |
|
Antipa Minerals Ltd
ASX:AZY
|
AU |
|
Five Below Inc
NASDAQ:FIVE
|
US |
|
Soditech SA
PAR:SEC
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CEPS's stock price target?
Not Available
CEPS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for CTI Biopharma Corp?
Projected CAGR
-35%
Over the last 8 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 4 years is -35%.